mRNA COVID-19 vaccines immunogenic in immunosuppressed patients
Sep 08, 2021
mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines appear to be immunogenic in patients receiving immunosuppressive medications for the management of chronic inflammatory...
New COVID-19 cases 300 percent higher this Labor Day weekend than last year
Sep 07, 2021
The surge in new cases could really hit a high point in about two weeks from now.
CDC: Unvaccinated should not travel this Labor Day weekend
Sep 01, 2021
The agency urges fully vaccinated people to travel with precautions and take infection risk into consideration.
Periodontitis may raise risk for new cardiovascular events
Sep 01, 2021
The presence of a severe gum infection at baseline was linked to increased odds for new cardiovascular events.
Walnut intake linked to modest decrease in LDL cholesterol in seniors
Aug 30, 2021
Significant decreases were seen in total cholesterol, LDL-C and intermediate density lipoprotein cholesterol, with no increase in weight.
Adverse events associated with BNT162b2 vaccination ID’d
Aug 27, 2021
Vaccination with the Pfizer–BioNTech mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with an increased risk for myocarditis and lymphadenopathy, according...
Dementia risk score linked to MRI markers of brain atrophy
Aug 26, 2021
Higher scores on the Lifestyle for Brain Health index were linked to higher volumes of white matter hyperintensities, lower scores for cognitive function.
Stop using ivermectin veterinary drug to treat COVID-19, FDA urges
Aug 23, 2021
No form of ivermectin has been approved to treat or prevent COVID-19, the agency emphasized.
Doctors more likely to test for conditions recently diagnosed in other patients
Aug 17, 2021
When seeing patients with shortness of breath, testing for pulmonary embolism increases for 10 days after a diagnosis in a patient with the condition.
Dexamethasone underused for adults hospitalized with COVID-19
Aug 16, 2021
Dexamethasone and remdesivir use gradually have increased during the pandemic; hydroxychloroquine use peaked in March 2020.